Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

Evotec (NASDAQ: EVO; Frankfurt: EVT) released preliminary, unaudited figures for Q2 and the first half of 2026 and revised its full-year 2026 outlook.

Rhea-AI Summary

Evotec (NASDAQ: EVO; Frankfurt: EVT) released preliminary, unaudited figures for Q2 and the first half of 2026 and revised its full-year 2026 outlook. For H1 2026, Evotec expects Group revenues of about €300.1 million and adjusted Group EBITDA of about -€42.7 million, with liquidity around €465.6 million as of 30 June 2026.

For full-year 2026, Evotec now forecasts Group revenues of approximately €570–610 million (€595–635 million CER) and adjusted Group EBITDA of approximately -€70 to -105 million (-€60 to -90 million CER. Previous guidance was €700–780 million (€730–810 million CER) for revenues and €0–40 million (€10–50 million CER) for adjusted EBITDA.

Positive

• H1 2026 revenues approximately €300.1 million
• Liquidity at 30 June 2026 approximately €465.6 million
• FY 2026 revenue guidance still €570–610 million

Negative

• FY 2026 revenue guidance cut from €700–780 million to €570–610 million
• FY 2026 adjusted EBITDA outlook reduced from €0–40 million to -€70 to -105 million
• H1 2026 adjusted EBITDA preliminary loss of approximately -€42.7 million

News Explained

Evotec’s preliminary first-half figures accompany a full-year outlook that now includes negative adjusted EBITDA, with €465.6 million of liquidity expected at June 30, 2026.

Evotec announced preliminary, unaudited second-quarter and first-half 2026 results and an updated full-year outlook, changing the company’s stated revenue and adjusted EBITDA expectations while leaving the final results pending.

For the first half, Evotec expects approximately €300.1 million of revenue and approximately -€42.7 million of adjusted Group EBITDA. The updated full-year revenue outlook is €570–610 million, compared with previous guidance of €700–780 million, while adjusted EBITDA is now expected at -€70 to -105 million versus previous guidance of €0–40 million.

Liquidity as of June 30, 2026 is expected to be approximately €465.6 million. Full second-quarter and first-half results remain scheduled for publication on August 13, 2026.

Argus Jul 13 session 13 alerts

-12.75% close to close 4.6x rel. volume Open Argus

Details

Market move: EVO -12.75% in the Jul 13 session. H1 2026 earnings guidance update

-11.1% Trough in 24 min

$1.01B Mkt Cap at Peak Alert

On Jul 13, the day this news came out, EVO closed 12.75% below the previous close. Argus tracked a trough of -11.1% from its starting point during tracking. Our momentum scanner recorded 13 alerts for this stock that day. Relative volume reached 4.6x the daily average during tracking.

Data tracked by StockTitan Argus for the Jul 13 session.

Key Figures

Group revenues: €300.1 million Adjusted Group EBITDA: -€42.7 million Liquidity: €465.6 million +5 more

Group revenues

€300.1 million

Preliminary H1 2026

Adjusted Group EBITDA

-€42.7 million

Preliminary H1 2026

Liquidity

€465.6 million

As of June 30, 2026

FY26 revenue guidance

€570–610 million

Updated full-year 2026

FY26 revenue guidance (CER)

€595–635 million

Updated full-year 2026

FY26 EBITDA guidance

-€70 to -105 million

Updated full-year 2026

Prior FY26 revenue guidance

€700–780 million

Previous full-year 2026 outlook

Prior FY26 EBITDA guidance

€0–40 million

Previous full-year 2026 outlook

Historical Context

5 past events · Latest: Jun 30

5 events

1. Jun 30

   platform launch

   24h Move

   +0.0%

   Launch of J.TRAIN turnkey continuous biologics manufacturing solution for partners.

2. Jun 11

   AGM results

   24h Move

   +4.2%

   Annual General Meeting approvals and Supervisory Board elections in Hamburg.

3. Jun 02

   leadership appointment

   24h Move

   -3.9%

   Appointment of Rui Wang as EVP, Head of Global In Silico and AI.

4. May 12

   convertible bond issue

   24h Move

   -9.5%

   Placement of €116.1 million senior unsecured convertible bonds due 2033.

5. May 04

   partner milestone

   24h Move

   +1.0%

   Nomination of first preclinical development candidate in Almirall dermatology collaboration.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ebitda, liquidity

2 terms

ebitda financial

"and adjusted Group EBITDA of approximately -€42.7 million."

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.

View in glossary

liquidity financial

"As of June 30, 2026, liquidity is expected to amount to approximately €465.6 million."

Liquidity is how easily and quickly an asset or investment can be converted into cash without losing value. It matters to investors because higher liquidity means they can access their money quickly if needed, while lower liquidity can make it harder to sell assets promptly or at a fair price, potentially creating financial challenges. Think of it like trying to sell a common item versus a rare collectible—it's much easier to sell the common item fast.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014 

HAMBURG, Germany, July 13, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for the second quarter and first half of 2026 and updated its full-year 2026 outlook. Full financial results for the second quarter and first half of 2026 will be published on August 13, 2026, as scheduled.

Based on preliminary figures, Evotec expects Group revenues for the first half of 2026 of approximately €300.1 million and adjusted Group EBITDA of approximately -€42.7 million. As of June 30, 2026, liquidity is expected to amount to approximately €465.6 million.

Reflecting these factors, Evotec now expects full-year 2026 Group revenues of approximately €570 to 610 million (€595 to 635 million CER) and adjusted Group EBITDA of approximately -€70 to -105 million (-€60 to -90 million CER). This compares with previous guidance of €700 to 780 million (€730 to 810 million CER) for Group revenues and €0 to 40 million (€10 to 50 million CER) for adjusted Group EBITDA.

Contact: Dr. Sarah Fakih, EVP Head of Global Communications and Investor Relations, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49 (0) 151 7068 8784 (m), sarah.fakih@evotec.com

www.evotec.com

View original content:https://www.prnewswire.com/news-releases/ad-hoc-evotec-announces-preliminary-second-quarter-and-first-half-2026-results-and-updates-full-year-2026-outlook-302824155.html

SOURCE Evotec SE

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What preliminary first half 2026 results did Evotec (EVO) report on July 13, 2026?

Evotec reported preliminary H1 2026 revenues of about €300.1 million and adjusted Group EBITDA of about -€42.7 million. According to Evotec, liquidity stood at approximately €465.6 million as of June 30, 2026, ahead of full results on August 13, 2026.

How did Evotec (EVO) change its full-year 2026 revenue guidance?

Evotec lowered its 2026 Group revenue guidance to approximately €570–610 million, from €700–780 million previously. According to Evotec, the new outlook also includes a constant-currency range of €595–635 million CER, reflecting updated expectations based on preliminary first half figures.

What is Evotec’s updated 2026 adjusted EBITDA outlook for EVO shareholders?

Evotec now expects 2026 adjusted Group EBITDA between -€70 and -105 million, versus prior guidance of €0–40 million. According to Evotec, the constant-currency range is -€60 to -90 million CER, indicating a shift from a previously anticipated positive result to a projected loss.

What liquidity does Evotec (EVO) expect as of June 30, 2026?

Evotec expects liquidity of approximately €465.6 million as of June 30, 2026. According to Evotec, this preliminary figure accompanies H1 2026 revenues of about €300.1 million and an adjusted Group EBITDA loss, providing investors with an early view of its financial position.

When will Evotec (EVO) publish its full second quarter and first half 2026 results?

Evotec plans to publish its full Q2 and H1 2026 financial results on August 13, 2026. According to Evotec, the July 13, 2026 announcement only provides preliminary, unaudited figures and an updated full-year 2026 outlook for revenues and adjusted Group EBITDA.

How do Evotec’s 2026 constant-currency (CER) guidance ranges compare to prior guidance?

Evotec’s 2026 revenue guidance in CER is now €595–635 million, down from €730–810 million. According to Evotec, adjusted Group EBITDA guidance in CER moved to -€60 to -90 million, compared with a previous range of €10–50 million, indicating reduced profitability expectations.